Back to Search Start Over

Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.

Authors :
Qiao, Pei-Pei
Tian, Kai-Sai
Han, Li-Tao
Ma, Ben
Shen, Cen-Kai
Zhao, Run-Yu
Zhang, Yi
Wei, Wen-Jun
Chen, Xiao-Ping
Source :
Endocrine (1355008X); Jun2022, Vol. 76 Issue 3, p660-670, 11p
Publication Year :
2022

Abstract

Background: Mutations in DNA mismatch repair (MMR) genes associated with thyroid carcinoma (TC) have rarely been reported, especially in East Asian populations. Methods: We examined tumor tissue from a cohort of 241 patients diagnosed with TC between 2008 and 2020. MMR proteins were detected using tissue microarray-based immunohistochemistry in order to identify MMR-protein-deficient (MMR-D) and MMR-protein-intact (MMR-I) tumors. We retrospectively summarized the clinicopathologic characteristics of patients with MMR-D TC, measured the expression of PD-L1, and recorded overall survival (OS) and other clinical outcomes. Results: In our cohort, there were 18 (7.5%) MMR-D (MLH1, MSH2, MSH6, and PMS2) patients, including 12 with papillary TC (PTC) (6.7%), 2 with poorly differentiated TC (PDTC) (4.7%), and 4 with anaplastic TC (ATC) (22.2%). Half of them (9/18) showed a specific deletion in MSH6, and 6 of them also carried variants in the MSH6 and PMS2 gene. Survival was significantly better in patients with MMR-D ATC than in those with MMR-I tumors (p = 0.033). Four of the 18 MMR-D patients (22%) were found to be PD-L1 positive. Their OS was much shorter than that of PD-L1-negative patients. Conclusions: MMR-D and PD-L1 positivity appear to be associated with clinicopathological characteristics and prognosis in TC. The results indicate that MMR status may have important prognostic significance in TC. Therefore, immune checkpoint inhibitors that target the PD-1/PD-L1 pathway may be a treatment option for TCs. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1355008X
Volume :
76
Issue :
3
Database :
Complementary Index
Journal :
Endocrine (1355008X)
Publication Type :
Academic Journal
Accession number :
157183958
Full Text :
https://doi.org/10.1007/s12020-022-03031-w